Does PEMBROLIZUMAB Cause Graft versus host disease? 25 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 25 reports of Graft versus host disease have been filed in association with PEMBROLIZUMAB (KEYTRUDA). This represents 0.0% of all adverse event reports for PEMBROLIZUMAB.
25
Reports of Graft versus host disease with PEMBROLIZUMAB
0.0%
of all PEMBROLIZUMAB reports
5
Deaths
4
Hospitalizations
How Dangerous Is Graft versus host disease From PEMBROLIZUMAB?
Of the 25 reports, 5 (20.0%) resulted in death, 4 (16.0%) required hospitalization, and 1 (4.0%) were considered life-threatening.
Is Graft versus host disease Listed in the Official Label?
Yes, Graft versus host disease is listed as a known adverse reaction in the official FDA drug label for PEMBROLIZUMAB.
What Other Side Effects Does PEMBROLIZUMAB Cause?
Malignant neoplasm progression (10,111)
Death (4,744)
Diarrhoea (4,251)
Fatigue (3,833)
Off label use (3,416)
Product use in unapproved indication (3,191)
Pyrexia (3,155)
Rash (2,900)
Nausea (2,670)
Decreased appetite (2,486)
What Other Drugs Cause Graft versus host disease?
CYCLOSPORINE (1,131)
TACROLIMUS (900)
MYCOPHENOLATE MOFETIL (890)
CYCLOPHOSPHAMIDE (653)
METHOTREXATE (615)
FLUDARABINE (541)
BUSULFAN (507)
RUXOLITINIB (469)
METHYLPREDNISOLONE (429)
PREDNISONE (405)
Which PEMBROLIZUMAB Alternatives Have Lower Graft versus host disease Risk?
PEMBROLIZUMAB vs PEMETREXED
PEMBROLIZUMAB vs PEMIGATINIB
PEMBROLIZUMAB vs PENICILLAMINE
PEMBROLIZUMAB vs PENICILLIN
PEMBROLIZUMAB vs PENICILLIN G